Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing MW05 with PEG-rhG-CSF in breast cancer indicates completion of the study.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery. [Phase 2]
Phase 2 trial comparing acute toxicity and cost between whole breast irradiation with sequential boost versus simultaneous integrated boost …
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients. [Phase 2]
Phase 2 neoadjuvant trial evaluating pyrotinib and trastuzumab with docetaxel and carboplatin in HER2-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors [Phase 2]
A Phase 2 clinical trial update evaluating [68Ga]Ga-ABY-025 PET for quantifying HER2 status in solid tumors, including esophageal and gastri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating Debio 1347 in combination with Fulvestrant for metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing margetuximab plus chemotherapy to trastuzumab plus chemotherapy in HER2-positive metastatic breast cancer; the study…
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating safety and efficacy of eribulin combined with anlotinib in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating pyrotinib in combination with trastuzumab and docetaxel for metastatic HER2-positive breast cancer is underway, wit…
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating SU11248 as consolidation after response to taxanes in metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Study on Androgen Receptor and Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update investigating androgen receptor targeted therapy in triple-negative breast cancer with androgen receptor positivity has…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) [Phase 3]
Trial update for the STARS Breast Trial (anastrozole and radiotherapy sequencing) in breast cancer; details on phase 3 status are currently …
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating Inetetamab plus Pyrotinib and chemotherapy for previously untreated HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: 68Ga PET/CT Imaging in Breast Cancer Patients [Phase 1, Phase 2]
Clinical trial update on 68Ga PET/CT imaging in breast cancer patients across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors [NA]
A completed clinical trial evaluating a small-group, virtual program to improve symptoms and distress related to hormonal therapy in breast …
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1 [Phase 2]
Phase 2 trial comparing Pertuzumab-Herceptin vs Pertuzumab-Herceptin with metronomic chemotherapy, followed by T-DM1 in elderly patients wit…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes [Phase 3]
A Phase 3 trial evaluating whether genetic testing or clinical assessment can determine the need for chemotherapy in women with breast cance…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer [Phase 3]
Phase 3 trial investigating the efficacy and safety of co-administering lansoprazole with neoadjuvant chemotherapy in women with breast canc…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant fluzoparib with camrelizumab in germline BRCA-mutated, HER2-negative breast cancer is currently enrolli…
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer [Phase 2, Phase 3]
A trial update for a platinum and polyadenosine 5'-diphosphoribose polymerisation inhibitor in neoadjuvant treatment for triple-negative bre…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB [NA]
Clinical trial update for a technology-supported physical activity intervention in metastatic breast cancer survivors (Fit2ThriveMB) with co…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer [Phase 2]
Phase 2 trial evaluating glucosamine and chondroitin for joint symptoms in women taking aromatase inhibitors for breast cancer; trial comple…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer [Phase 3]
Phase 3 trial comparing hypofractionated vs normofractionated IMRT for breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca [Phase 1, Phase 2]
A Phase I/II study evaluating weekly Abraxane (paclitaxel protein-bound) plus RAD001 (everolimus) in women with locally advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor. [Phase 2]
Phase 2 trial examining tucidinostat with metronomic capecitabine and endocrine therapy for advanced HR-positive, HER2-negative breast cance…